Specialized niche Target topoisomerase researchers and drug discovery teams with bespoke in vitro and in vivo assay kits and DNA substrates, highlighting deep domain expertise and a track record since the 1990s.

In house screening Leverage their contract screening services featuring mechanism-based, in house developed cell-based screens to position as a partner for collaborators seeking cancer and antibacterial topoisomerase inhibitors.

Global support Emphasize ongoing product support, data interpretation, and consultation as a differentiator to win customers who value ongoing collaboration and scientific partnership.

Strategic expansion Capitalize on their recent Colorado expansion to approach nearby academic and biotech centers with research infrastructure aligned to topoisomerase biology and drug discovery workflows.

Product breadth Promote the full portfolio of DNA substrates, inhibitors, antibodies, assay kits, and replenishment reagents as a one-stop solution for topoisomerase research and assay development needs.